Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy | NEJM
The alternative complement pathway plays a key role in the pathogenesis of IgA nephropathy. Iptacopan specifically binds to factor B and inhibits the alternative pathway. In this phase 3, double-bl…